Guillain-Barré syndrome is the most common cause of acute flaccid paralysis worldwide.
Most patients present with an antecedent illness, most commonly upper respiratory tract …

Coronavirus 2019 (COVID-19) has created a global pandemic that is devastating human
lives, public healthcare systems, and global economies. Multiple effective and safe COVID …

Abstract Reports of Guillain-Barré syndrome (GBS) have emerged during the Coronavirus
disease 2019 (COVID-19) pandemic. This epidemiological and cohort study sought to …

Objective To determine the prevalence and associated mortality of well-defined neurologic
diagnoses among patients with coronavirus disease 2019 (COVID-19), we prospectively …

Objective Single cases and small series of Guillain-Barré syndrome (GBS) have been
reported during the SARS-CoV-2 outbreak worldwide. We evaluated incidence and clinical …

Background Little is known regarding long-term outcomes of patients hospitalized with
COVID-19. Methods We conducted a prospective study of 6-month outcomes of hospitalized …

We diagnosed 11 Guillain–Barré syndrome (GBS) cases among 71,904 COVID patients
attended at 61 Spanish emergency departments (EDs) during the 2‐month pandemic peak …

Vaccines are the most effective strategy to mitigate the global impact of COVID-19. However,
vaccine hesitancy is common, particularly among minorities. Guillain-Barré syndrome (GBS) …

In the wake of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic, an increasing number of patients with neurological disorders, including Guillain …

Background Novel approaches are required to improve outcomes in relapsed or refractory
classical Hodgkin lymphoma and non-Hodgkin lymphoma. We aimed to evaluate …